IL161193A0 - Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease - Google Patents
Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's diseaseInfo
- Publication number
- IL161193A0 IL161193A0 IL16119301A IL16119301A IL161193A0 IL 161193 A0 IL161193 A0 IL 161193A0 IL 16119301 A IL16119301 A IL 16119301A IL 16119301 A IL16119301 A IL 16119301A IL 161193 A0 IL161193 A0 IL 161193A0
- Authority
- IL
- Israel
- Prior art keywords
- crohn
- disease
- treatment
- pharmaceutical composition
- ulcerative colitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/DK2001/000677 WO2003032952A1 (en) | 2001-10-15 | 2001-10-15 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161193A0 true IL161193A0 (en) | 2004-08-31 |
Family
ID=8149447
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16119301A IL161193A0 (en) | 2001-10-15 | 2001-10-15 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| IL161193A IL161193A (en) | 2001-10-15 | 2004-03-31 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL161193A IL161193A (en) | 2001-10-15 | 2004-03-31 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1441700B1 (ja) |
| JP (1) | JP4726414B2 (ja) |
| KR (1) | KR100859358B1 (ja) |
| CN (1) | CN100506234C (ja) |
| AT (1) | ATE371441T1 (ja) |
| CA (1) | CA2462905C (ja) |
| DE (1) | DE60130270T2 (ja) |
| DK (1) | DK1441700T3 (ja) |
| ES (1) | ES2288999T3 (ja) |
| HK (1) | HK1068282A1 (ja) |
| IL (2) | IL161193A0 (ja) |
| MX (1) | MXPA04003506A (ja) |
| NO (1) | NO335042B1 (ja) |
| PT (1) | PT1441700E (ja) |
| WO (1) | WO2003032952A1 (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070059368A1 (en) * | 2005-05-31 | 2007-03-15 | Cherukuri S R | Modified release formulations of anti-irritability drugs |
| JP2007523664A (ja) * | 2003-04-23 | 2007-08-23 | フェリング ベスローテン フェンノートシャップ | 医薬組成物用サシェ |
| EP1470819A1 (en) * | 2003-04-23 | 2004-10-27 | Ferring B.V. | High drug load mesalazine sachet |
| EP1547601A1 (en) * | 2003-12-23 | 2005-06-29 | Ferring B.V. | Coating method |
| WO2006028831A2 (en) * | 2004-09-01 | 2006-03-16 | The Procter & Gamble Company | Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar |
| GB0909680D0 (en) | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
| EP2340812A1 (en) * | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granules for pharmaceutical preparations, methods and apparatus for their production |
| US20130225539A1 (en) * | 2010-09-10 | 2013-08-29 | Pharmazell Gmbh | Method for producing crystalline 5-aminosalicylic acid |
| WO2013134348A1 (en) * | 2012-03-07 | 2013-09-12 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
| CN103622974B (zh) * | 2013-12-05 | 2016-04-20 | 武汉武药科技有限公司 | 一种含美沙拉嗪和n-乙酰半胱氨酸的复方栓剂及其制备方法 |
| EP3154523B1 (en) * | 2014-06-16 | 2018-11-21 | Valpharma International S.P.A. | Formulation for oral administration containing mesalazine |
| ITUA20162293A1 (it) | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
| JP2017189121A (ja) * | 2016-04-11 | 2017-10-19 | 国立大学法人旭川医科大学 | 抗ＴＮＦα抗体適応疾患の治療における抗ＴＮＦα抗体投与時反応の発症リスクを判定する方法、並びに該判定用オリゴヌクレオチドキット |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57500432A (ja) * | 1980-03-20 | 1982-03-11 | ||
| JPH0334928A (ja) * | 1989-06-29 | 1991-02-14 | Teikoku Seiyaku Kk | 潰瘍性大腸炎およびクローン病治療用経口投与製剤 |
| CN1155369C (zh) * | 1995-12-21 | 2004-06-30 | 药物实验室费林公司 | 含有5-asa的控释口服药物组合物及其治疗肠道疾病的方法 |
| IT1303753B1 (it) * | 1998-11-13 | 2001-02-23 | Ct Lab Farm Srl | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. |
| IT1318625B1 (it) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
-
2001
- 2001-10-15 CA CA2462905A patent/CA2462905C/en not_active Expired - Lifetime
- 2001-10-15 WO PCT/DK2001/000677 patent/WO2003032952A1/en active IP Right Grant
- 2001-10-15 CN CNB018237096A patent/CN100506234C/zh not_active Expired - Lifetime
- 2001-10-15 AT AT01978213T patent/ATE371441T1/de active
- 2001-10-15 IL IL16119301A patent/IL161193A0/xx unknown
- 2001-10-15 KR KR1020047005406A patent/KR100859358B1/ko active IP Right Grant
- 2001-10-15 ES ES01978213T patent/ES2288999T3/es not_active Expired - Lifetime
- 2001-10-15 DK DK01978213T patent/DK1441700T3/da active
- 2001-10-15 MX MXPA04003506A patent/MXPA04003506A/es active IP Right Grant
- 2001-10-15 PT PT01978213T patent/PT1441700E/pt unknown
- 2001-10-15 EP EP01978213A patent/EP1441700B1/en not_active Expired - Lifetime
- 2001-10-15 JP JP2003535756A patent/JP4726414B2/ja not_active Expired - Lifetime
- 2001-10-15 DE DE60130270T patent/DE60130270T2/de not_active Expired - Lifetime
-
2004
- 2004-03-31 IL IL161193A patent/IL161193A/en not_active IP Right Cessation
- 2004-05-14 NO NO20042011A patent/NO335042B1/no not_active IP Right Cessation
-
2005
- 2005-01-24 HK HK05100633A patent/HK1068282A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN100506234C (zh) | 2009-07-01 |
| EP1441700B1 (en) | 2007-08-29 |
| EP1441700A1 (en) | 2004-08-04 |
| CA2462905C (en) | 2011-04-12 |
| KR100859358B1 (ko) | 2008-09-22 |
| JP4726414B2 (ja) | 2011-07-20 |
| ATE371441T1 (de) | 2007-09-15 |
| PT1441700E (pt) | 2007-10-29 |
| CN1558752A (zh) | 2004-12-29 |
| HK1068282A1 (en) | 2005-04-29 |
| NO335042B1 (no) | 2014-09-01 |
| JP2005509619A (ja) | 2005-04-14 |
| WO2003032952A1 (en) | 2003-04-24 |
| DE60130270D1 (de) | 2007-10-11 |
| DK1441700T3 (da) | 2007-10-08 |
| IL161193A (en) | 2010-05-31 |
| MXPA04003506A (es) | 2004-07-23 |
| NO20042011L (no) | 2004-06-30 |
| ES2288999T3 (es) | 2008-02-01 |
| DE60130270T2 (de) | 2008-05-29 |
| KR20040047906A (ko) | 2004-06-05 |
| CA2462905A1 (en) | 2003-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1068282A1 (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for usein treatment of ulcerative colitis and crohn's di sease | |
| TNSN07290A1 (en) | Gastroresistant pharmaceutical formulations containing rifaximin | |
| HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| HK1048986A1 (en) | 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds. | |
| TR200200716T2 (tr) | Ketiyapin granülleri | |
| DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
| MY137570A (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease | |
| WO2000072823A8 (en) | Preparations for the application of anti-inflammatory agents | |
| HUP0302538A3 (en) | 3,7-diazabicyclo[3.3.0]oczanes and their use in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them | |
| HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
| HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| SE0001916D0 (sv) | Novel formulation | |
| HUP0102987A3 (en) | Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
| WO2001068676A3 (de) | Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel | |
| HK1075654A1 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
| HK1065305A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| PL369504A1 (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease | |
| DK1275383T3 (da) | "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof | |
| NZ532449A (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and Crohn's disease | |
| Sadikov et al. | Development and introduction of the novel domestic anthelmintic agent albendazole | |
| Ball | A dose of Paracelsus | |
| HUP9802896A3 (en) | Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| WO2004078761A8 (en) | Enantiomerically pure cilazapril,process for preparation | |
| UY27472A1 (es) | Metodo para la preparación de una composición farmacéutica que comprende un acido-5-amino-salicilico, para uso en el tratamiento de la colitis ulcerosa y enfermedad de crohn. |